Stock NXGL NEXGEL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

NEXGEL, Inc. Stock

Equities

NXGL

US65344E1073

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.21 USD -3.28% Intraday chart for NEXGEL, Inc. +1.84% +3.76%
Apr. 01 NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 01 Transcript : NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024

Financials (USD)

Sales 2024 * 6.17M Sales 2025 * 9.32M Capitalization 13.76M
Net income 2024 * -4M Net income 2025 * - EV / Sales 2024 * 2.23 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.48 x
P/E ratio 2024 *
-3.3 x
P/E ratio 2025 *
-27.6 x
Employees 19
Yield 2024 *
-
Yield 2025 *
-
Free-Float 77.18%
More Fundamentals * Assessed data

Chart NEXGEL, Inc.

Dynamic Chart

Latest news about NEXGEL, Inc.

NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024
Earnings Flash (NXGL) NEXGEL Posts Q4 Revenue $1.1M MT
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023 CI
NEXGEL, Inc. Announces Intention of Miranda J. Toledano to Resign as a Member of the Board of Directors, Effective as of March 31, 2024 CI
Top Premarket Decliners MT
Nexgel Subsidiary, Cg Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024 CI
NEXGEL, Inc. Announces Resignation of David Stefansky as Member of the Board of Directors CI
Nexgel Enters Deal With Stada Arzneimittel to Distribute OTC Products Across North America MT
NEXGEL, Inc. Announces Partnership with STADA Arzneimittel AG to Distribute and Commercialize Consumer Health OTC Products in North America CI
NEXGEL, Inc. acquired Kenkoderm from Olympus Trading Company, LLC for $1.1 million. CI
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022. CI
NEXGEL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : NEXGEL, Inc., Q3 2023 Earnings Call, Nov 13, 2023
Earnings Flash (NXGL) NEXGEL Reports Q3 Revenue $1.2M, vs. Street Est of $1.2M MT
More news

Latest transcript on NEXGEL, Inc.

Logo NEXGEL, Inc.
NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024
More transcripts

Press releases NEXGEL, Inc.

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024 AQ
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year AQ
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday AQ
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th AQ
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th AQ
More press releases

Quotes and Performance

1 day-3.28%
1 week+1.84%
Current month-19.05%
1 month-19.05%
3 months+0.00%
6 months+38.12%
Current year+3.76%
More quotes

Highs and lows

1 week
2.17
Extreme 2.17
2.36
1 month
1.98
Extreme 1.98
2.78
Current year
1.98
Extreme 1.98
3.14
1 year
1.40
Extreme 1.4
3.14
3 years
1.09
Extreme 1.09
4.66
5 years
1.09
Extreme 1.09
4.66
10 years
1.09
Extreme 1.09
4.66
More quotes

Managers and Directors - NEXGEL, Inc.

Managers TitleAgeSince
Adam Levy CEO
 Chief Executive Officer 61 19-09-09
Adam Drapczuk DFI
 Director of Finance/CFO 48 21-05-31
Gregory J. Robb COO
 Chief Operating Officer - -
Members of the board TitleAgeSince
Scott Henry BRD
 Director/Board Member 53 23-01-15
Nachum Stein BRD
 Director/Board Member 75 19-09-09
Jerome Zeldis BRD
 Director/Board Member 74 20-03-31
More insiders

Quotes

Date Price Change Volume
24-04-26 2.21 -3.28% 7,486
24-04-25 2.285 +3.39% 6,570
24-04-24 2.21 +0.46% 5,592
24-04-23 2.2 +0.92% 1,442
24-04-22 2.18 +0.46% 10,190

Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT

More quotes

Company Profile

NexGel, Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its gels and its consumer products are manufactured using proprietary and non-proprietary mixing, coating, and crosslinking technologies. It markets under the brand names MedaGel and LumaGel Beauty. The products it sells under its MedaGel brand primarily relate to over the counter (OTC) remedy solutions, such as blister and pain applications; while the products it sells under its LumaGel Beauty brand primarily relate to beauty and cosmetic solutions, such as wrinkle and skin cream applications. The Company is also engaged in treating the symptoms of Psoriasis through its brand Kenkoderm.
Sector
Pharmaceuticals
Calendar
2024-05-01 - Planet MicroCap Showcase
More about the company

Income Statement Evolution

More financial data

Ratings for NEXGEL, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.21 USD
Average target price
6 USD
Spread / Average Target
+171.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
NEXGEL, INC. Stock NEXGEL, Inc.
+3.76% 13.76M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NXGL Stock